Esperion Th (ESPR) Insider Trading
- $64,409,919.21
- $88,568,137.49
- Oct. 17, 2024
- Target N V Biotech
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Nov. 5, 2018 | Major Shareholder | 100,000 | $56.38 | Sell | $5,638,000.00 | |
| Nov. 2, 2018 | Director | 2,827 | $50.07 | Sell | $141,547.89 | |
| Nov. 2, 2018 | Major Shareholder | 40,000 | $55.21 | Sell | $2,208,400.00 | |
| Oct. 18, 2018 | Director | 100 | $50.00 | Sell | $5,000.00 | |
| Oct. 16, 2018 | Director | 9,400 | $50.01 | Sell | $470,094.00 | |
| Aug. 27, 2018 | Director | 17,700 | $51.05 | Sell | $903,585.00 | |
| Aug. 17, 2018 | Director | 7,300 | $50.06 | Sell | $365,438.00 | |
| Aug. 3, 2018 | Major Shareholder | 50,000 | $46.14 | Buy | $2,307,000.00 | |
| July 12, 2018 | Major Shareholder | 50,000 | $41.77 | Buy | $2,088,500.00 | |
| June 29, 2018 | Major Shareholder | 50,000 | $39.48 | Buy | $1,974,000.00 | |
| June 21, 2018 | Major Shareholder | 60,000 | $38.57 | Buy | $2,314,200.00 | |
| June 7, 2018 | Major Shareholder | 60,000 | $37.79 | Buy | $2,267,400.00 | |
| June 5, 2018 | Major Shareholder | 60,000 | $38.47 | Buy | $2,308,200.00 | |
| May 21, 2018 | Major Shareholder | 130,000 | $40.11 | Buy | $5,214,300.00 | |
| May 18, 2018 | Major Shareholder | 50,000 | $42.24 | Buy | $2,112,000.00 | |
| March 29, 2018 | Director | 25,000 | $72.37 | Sell | $1,809,250.00 | |
| Jan. 25, 2018 | Director | 11,674 | $71.79 | Sell | $838,076.46 | |
| Dec. 6, 2017 | Director | 9,326 | $53.85 | Sell | $502,205.10 | |
| March 22, 2017 | Director | 800,000 | $41.66 | Sell | $33,328,000.00 | |
| March 21, 2017 | Director | 1,000 | $42.26 | Buy | $42,260.00 | |
| Nov. 1, 2016 | COO | 5,000 | $9.93 | Buy | $49,650.00 | |
| July 6, 2016 | Director | 5,000 | $10.00 | Buy | $50,000.00 | |
| May 4, 2016 | CEO | 7,000 | $14.85 | Buy | $103,950.00 | |
| March 1, 2016 | Director | 5,000 | $15.28 | Buy | $76,400.00 | |
| Jan. 27, 2016 | CEO | 3,600 | $15.88 | Buy | $57,168.00 | |
| Jan. 15, 2016 | CEO | 7,200 | $14.08 | Buy | $101,376.00 | |
| April 24, 2015 | Director | 217,469 | $108.22 | Sell | $23,534,495.18 | |
| Nov. 18, 2014 | Director | 487,130 | $32.78 | Sell | $15,968,121.40 | |
| Oct. 21, 2014 | Major Shareholder | 500,000 | $20.00 | Buy | $10,000,000.00 | |
| Oct. 7, 2014 | Major Shareholder | 11,927 | $30.04 | Sell | $358,287.08 | |
| July 1, 2013 | CEO | 5,000 | $14.00 | Buy | $70,000.00 | |
| July 1, 2013 | Director | 235,714 | $14.00 | Buy | $3,299,996.00 | |
| July 1, 2013 | Major Shareholder | 285,714 | $14.00 | Buy | $3,999,996.00 | |
| July 1, 2013 | Chairman | 42,346 | $14.00 | Buy | $592,844.00 |
Insiders are both buying and selling Esperion Th stock.
The insider traders at Esperion Th are: Target N V Biotech, Timothy M Mayleben, Eric Warren, Roger S Newton, Sheldon L Koenig, Joanne M Foody, Nicole Vitullo, Benjamin Looker, Boxer Capital, Llc, Dov A Md Goldstein, Gilbert S Omenn, Narendra D Lalwani, Mark E Mcgovern, Parters Vii L P Domain, Patrick G Enright, Richard Bartram, Longitude Capital Partners, Ll, J Martin Carroll, Daniel Janney, and Brian H Dovey
The most active insider trader at Esperion Th is Target N V Biotech with 17 trades.
Dov A Md Goldstein has sold the most Esperion Th stock with a total value of $90,190,495.18.
Target N V Biotech has bought the most Esperion Th stock with a total value of $48,059,800.00.
The most recent insider trade for Esperion Th was on Oct. 17, 2024.
The single biggest insider buy for Esperion Th was from Parters Vii L P Domain with a total value of $10,000,000.00 on Oct. 21, 2014.
The single biggest insider sell for Esperion Th was from Dov A Md Goldstein with a total value of $33,328,000.00 on March 22, 2017.